The TERT C228T mutation was detected in the plasma of 42 of the 95 HCC patients (44%), not in the plasma of any patients with liver cirrhosis, and in tumor tissue of 68% of HCC biopsy samples. The gene discussed is TERT; the disease is hepatocellular carcinoma.